A Study of Samuraciclib and Elacestrant in Participants With Metastatic or Locally Advanced HR+/HER2-negative Breast Cancer

Conditions:   Metastatic Breast Cancer;   Locally Advanced Breast Cancer;   Breast Cancer Interventions:   Drug: Samuraciclib;   Drug: Elacestrant Dihydrochloride Sponsors:   Carrick Therapeutics Limited;   Berlin-Chemie AG Menarini Group Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials